Webinar: Biden, Congress, and Drug Prices

Drug pricing is being targeted by both the Biden administration and congress, according to a webinar now available on Research and Markets. The webinar covers how the current administration is reacting to leftovers from the Trump presidency and how Biden’s executive orders may impact patients and payers. Furthermore, It breaks down the legislative status of bills with provisions impacting drug pricing.

According to Research and Markets, the webinar is tailored to, “Executives of pharmaceutical manufactures, drug distributors, benefit managers, health insurers/ payers, provider organizations, law firms, and consulting groups who have an interest in federal policy affecting prescription drug pricing in the U.S.”

Purchase access to the webinar by clicking here.

(Source: Research and Markets, November, 2021)